Fig. 7
From: Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
AEBP1 silencing sensitizes CAR cells to SSZ treatment in vivo. A-C. Tumor volume, tumor weight and body weight in sh-NC, sh-NC + cisplatin, sh-AEBP1 and sh-AEBP1 + cisplatin groups. **P < 0.01 versus sh-NC. #P < 0.05, ##P < 0.01 versus sh-NC + cisplatin. D-F Tumor volume, tumor weight and body weight in sh-NC, sh-NC + SSZ, sh-AEBP1 and sh-AEBP1 + SSZ groups. *P < 0.05, **P < 0.01 versus sh-NC. #P < 0.05, ##P < 0.01 versus sh-NC + SSZ